U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• Why aren't there any Indian girls married to Chinese guys but Chinese girls married to Indian guys?
• Father’s Day 2025: 28 gifts dads will actually want - The Verge
• How many women have accidentally pooped their pants and became turned on afterwards?
• As a guy, how do you know you if you are considered attractive?
• 8 signs you're mentally stronger than 95% of people, according to psychology - VegOut
• Reports: Bills RB James Cook ‘won’t be in Buffalo anytime soon’ - Buffalo Rumblings
• It seems that I am cursed with bad luck. How do I break such a curse?
• Did you know God exists? 900+ answers later and no atheist has yet to be successful. Day 8 of asking Atheists to provide a SINGLE argument that demonstrates a cause for the beginning of the universe while avoiding the problem of infinite regression.
• Why don't some people like the 10 Commandments?
• Yale’s new Google Home smart lock is here — but it costs more thanks to tariffs - The Verge
• Must-Play Cyberpunk 2077 Side-Quests, Mario Kart World Pointers And More Of The Week's Top Tips - Kotaku